About Epic Sciences
Epic Sciences is a company based in San Diego (United States) founded in 2008.. Epic Sciences has raised $204.5 million across 7 funding rounds from investors including LabCorp, Roche and ARE. The company has 98 employees as of December 31, 2022. Epic Sciences offers products and services including AR-V7 Test and Biopharma Solutions. Epic Sciences operates in a competitive market with competitors including Guardant Health, GRAIL, Foundation Medicine, ArcherDX and Natera, among others.
- Headquarter San Diego, United States
- Employees 98 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Epic Sciences, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$204.5 M (USD)
in 7 rounds
-
Latest Funding Round
$24 M (USD), Series G
Apr 14, 2023
-
Investors
LabCorp
& 17 more
-
Employee Count
98
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Epic Sciences
Epic Sciences offers a comprehensive portfolio of products and services, including AR-V7 Test and Biopharma Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Liquid biopsy test for prostate cancer therapy selection.
Platform for cancer research and drug development insights.
Unlock access to complete
Funding Insights of Epic Sciences
Epic Sciences has successfully raised a total of $204.5M across 7 strategic funding rounds. The most recent funding activity was a Series G round of $24 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series G — $24.0M
-
First Round
First Round
(30 Jun 2009)
- Investors Count 18
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2023 | Amount | Series G - Epic Sciences | Valuation | Deerfield , Arsenal Capital Partners | |
| Jun, 2022 | Amount | Series F - Epic Sciences | Valuation | Arsenal Capital Partners | |
| Sep, 2018 | Amount | Series E - Epic Sciences | Valuation | Blue Ox Healthcare Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Epic Sciences
Epic Sciences has secured backing from 18 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp, Roche and ARE. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Private equity investments target specialty industrials and healthcare sectors.
|
Founded Year | Domain | Location | |
|
Commercial-ready healthcare innovators are targeted for private equity investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Epic Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Epic Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Epic Sciences Comparisons
Competitors of Epic Sciences
Epic Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Foundation Medicine, ArcherDX and Natera, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Epic Sciences
Frequently Asked Questions about Epic Sciences
When was Epic Sciences founded?
Epic Sciences was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Where is Epic Sciences located?
Epic Sciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Epic Sciences a funded company?
Epic Sciences is a funded company, having raised a total of $204.5M across 7 funding rounds to date. The company's 1st funding round was a Series E of $52M, raised on Jun 30, 2009.
How many employees does Epic Sciences have?
As of Dec 31, 2022, the latest employee count at Epic Sciences is 98.
What does Epic Sciences do?
Provider of non-invasive tests for the detection of circulating tumor cells. The proprietary platform uses specialized assays and advanced digital pathology algorithms to identify circulating tumor cells from whole blood. The flagship product is Epic AR-V7 which detects the presence of AR-V7 biomarker in whole blood and associates it with the response rate for treatment with Zytiga and Xtandi. The first proposed application is metastatic castration-resistant prostate cancer.
Who are the top competitors of Epic Sciences?
Epic Sciences's top competitors include Guardant Health, GRAIL and Strand Life Sciences.
What products or services does Epic Sciences offer?
Epic Sciences offers AR-V7 Test and Biopharma Solutions.
Who are Epic Sciences's investors?
Epic Sciences has 18 investors. Key investors include LabCorp, Roche, ARE, Varian, and Arsenal Capital Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.